The effects of topical sodium cromoglicate on itch and flare in human skin induced by intradermal histamine: a randomised double-blind vehicle controlled intra-subject design trial
<p>Abstract</p> <p>Background</p> <p>Itch is a prominent feature of many skin diseases, particularly atopic dermatitis and cutaneous mastocytosis. Sodium cromoglicate (SCG), a chromone developed for the treatment of allergic disease has been shown to reduce the severity...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-03-01
|
Series: | BMC Research Notes |
Online Access: | http://www.biomedcentral.com/1756-0500/4/47 |
id |
doaj-46f9bb5c2a134a508c16cc32ed8f3dda |
---|---|
record_format |
Article |
spelling |
doaj-46f9bb5c2a134a508c16cc32ed8f3dda2020-11-25T01:31:28ZengBMCBMC Research Notes1756-05002011-03-01414710.1186/1756-0500-4-47The effects of topical sodium cromoglicate on itch and flare in human skin induced by intradermal histamine: a randomised double-blind vehicle controlled intra-subject design trialStevens Michael TChurch Martin KEdwards Alan M<p>Abstract</p> <p>Background</p> <p>Itch is a prominent feature of many skin diseases, particularly atopic dermatitis and cutaneous mastocytosis. Sodium cromoglicate (SCG), a chromone developed for the treatment of allergic disease has been shown to reduce the severity of itch when applied topically to subjects with atopic dermatitis. The aim of this study was to investigate whether topical sodium cromoglicate can reduce the severity of itch induced by intradermal histamine.</p> <p>Methods</p> <p>SCG was introduced into the skin of healthy volunteers both by iontophoresis and by topical application using a new 4% cutaneous emulsion (Altoderm™). The skin was then challenged with intradermal histamine. Measurements were made of severity of itch, size of wheal and flare and change in blood flux</p> <p>Results</p> <p>SCG significantly reduced the severity of itch (<it>P </it>= 0.0045) and flare (<it>P </it>= 0.0143) when delivered by iontophoresis. SCG 4% cutaneous emulsion significantly reduced severity of itch (<it>P </it>= 0.024) and flare (<it>P </it>= 0.015) in atopic subjects. Trend analysis showed increasing effect on itch with increased concentrations of SCG, which was significant (<it>P </it>= 0.046). There were no effects on wheal or blood flux.</p> <p>Conclusions</p> <p>Topically applied SCG, administered in a new cutaneous emulsion base, significantly reduced the itch and flare caused by intradermal histamine. The effect was greatest in atopic subjects and increased with the concentration of SCG in the emulsion.</p> <p>Trial registration</p> <p><a href="http://www.controlled-trials.com/ISRCTN35671014">ISRCTN35671014</a></p> http://www.biomedcentral.com/1756-0500/4/47 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Stevens Michael T Church Martin K Edwards Alan M |
spellingShingle |
Stevens Michael T Church Martin K Edwards Alan M The effects of topical sodium cromoglicate on itch and flare in human skin induced by intradermal histamine: a randomised double-blind vehicle controlled intra-subject design trial BMC Research Notes |
author_facet |
Stevens Michael T Church Martin K Edwards Alan M |
author_sort |
Stevens Michael T |
title |
The effects of topical sodium cromoglicate on itch and flare in human skin induced by intradermal histamine: a randomised double-blind vehicle controlled intra-subject design trial |
title_short |
The effects of topical sodium cromoglicate on itch and flare in human skin induced by intradermal histamine: a randomised double-blind vehicle controlled intra-subject design trial |
title_full |
The effects of topical sodium cromoglicate on itch and flare in human skin induced by intradermal histamine: a randomised double-blind vehicle controlled intra-subject design trial |
title_fullStr |
The effects of topical sodium cromoglicate on itch and flare in human skin induced by intradermal histamine: a randomised double-blind vehicle controlled intra-subject design trial |
title_full_unstemmed |
The effects of topical sodium cromoglicate on itch and flare in human skin induced by intradermal histamine: a randomised double-blind vehicle controlled intra-subject design trial |
title_sort |
effects of topical sodium cromoglicate on itch and flare in human skin induced by intradermal histamine: a randomised double-blind vehicle controlled intra-subject design trial |
publisher |
BMC |
series |
BMC Research Notes |
issn |
1756-0500 |
publishDate |
2011-03-01 |
description |
<p>Abstract</p> <p>Background</p> <p>Itch is a prominent feature of many skin diseases, particularly atopic dermatitis and cutaneous mastocytosis. Sodium cromoglicate (SCG), a chromone developed for the treatment of allergic disease has been shown to reduce the severity of itch when applied topically to subjects with atopic dermatitis. The aim of this study was to investigate whether topical sodium cromoglicate can reduce the severity of itch induced by intradermal histamine.</p> <p>Methods</p> <p>SCG was introduced into the skin of healthy volunteers both by iontophoresis and by topical application using a new 4% cutaneous emulsion (Altoderm™). The skin was then challenged with intradermal histamine. Measurements were made of severity of itch, size of wheal and flare and change in blood flux</p> <p>Results</p> <p>SCG significantly reduced the severity of itch (<it>P </it>= 0.0045) and flare (<it>P </it>= 0.0143) when delivered by iontophoresis. SCG 4% cutaneous emulsion significantly reduced severity of itch (<it>P </it>= 0.024) and flare (<it>P </it>= 0.015) in atopic subjects. Trend analysis showed increasing effect on itch with increased concentrations of SCG, which was significant (<it>P </it>= 0.046). There were no effects on wheal or blood flux.</p> <p>Conclusions</p> <p>Topically applied SCG, administered in a new cutaneous emulsion base, significantly reduced the itch and flare caused by intradermal histamine. The effect was greatest in atopic subjects and increased with the concentration of SCG in the emulsion.</p> <p>Trial registration</p> <p><a href="http://www.controlled-trials.com/ISRCTN35671014">ISRCTN35671014</a></p> |
url |
http://www.biomedcentral.com/1756-0500/4/47 |
work_keys_str_mv |
AT stevensmichaelt theeffectsoftopicalsodiumcromoglicateonitchandflareinhumanskininducedbyintradermalhistaminearandomiseddoubleblindvehiclecontrolledintrasubjectdesigntrial AT churchmartink theeffectsoftopicalsodiumcromoglicateonitchandflareinhumanskininducedbyintradermalhistaminearandomiseddoubleblindvehiclecontrolledintrasubjectdesigntrial AT edwardsalanm theeffectsoftopicalsodiumcromoglicateonitchandflareinhumanskininducedbyintradermalhistaminearandomiseddoubleblindvehiclecontrolledintrasubjectdesigntrial AT stevensmichaelt effectsoftopicalsodiumcromoglicateonitchandflareinhumanskininducedbyintradermalhistaminearandomiseddoubleblindvehiclecontrolledintrasubjectdesigntrial AT churchmartink effectsoftopicalsodiumcromoglicateonitchandflareinhumanskininducedbyintradermalhistaminearandomiseddoubleblindvehiclecontrolledintrasubjectdesigntrial AT edwardsalanm effectsoftopicalsodiumcromoglicateonitchandflareinhumanskininducedbyintradermalhistaminearandomiseddoubleblindvehiclecontrolledintrasubjectdesigntrial |
_version_ |
1725086502884474880 |